LINC00964

Across TCGA pan-cancer cohorts, LINC00964 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00964 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC00964 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00964 expression acts as an unfavorable survival marker, although some lineages such as LIHC and KIRC show a favorable association.

LIHC, UVM, and DLBC are the cancer types where LINC00964 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	III,IV	0.663	0.238	<.001	38	view →
UVM	DFS	Quartile	All	0.382	0.876	.005	37	view →
DLBC	OS	Tertile	III,IV	0.249	0.955	<.001	30	view →
KIRC	OS	Quartile	All	0.736	0.576	.003	27	view →
BLCA	DFS	Tertile	All	0.522	0.655	.003	26	view →
LGG	DFS	Quartile	All	0.769	0.908	<.001	18	view →
SKCM	DFS	Median	All	0.263	0.154	.003	17	view →
ESCA	OS	Quartile	III,IV	0.772	0.469	.019	16	view →
SARC	OS	Quartile	All	0.307	0.536	.003	15	view →
ACC	OS	Tertile	II,III,IV	0.753	0.942	.013	11	view →
CESC	DFS	Quartile	II,III,IV	0.352	0.722	.030	6	view →
COAD	OS	Median	All	0.473	0.668	.016	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC00964–LIHC (DFS)

Open the LIHC breakdown →